Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Combination therapy for kidney disease in people with diabetes mellitus

    Diabetic kidney disease (DKD), defined as co-existing diabetes and chronic kidney disease in the absence of other clear causes of kidney injury, occurs in approximately 20–40% of patients with diabetes mellitu...

    Daniël H. van Raalte, Petter Bjornstad, David Z. I. Cherney in Nature Reviews Nephrology (2024)

  2. No Access

    Article

    Trajectories of eGFR and risk of albuminuria in youth with type 2 diabetes: results from the TODAY cohort study

    We conducted exploratory analyses to identify distinct trajectories of estimated glomerular filtration rate (eGFR) and their relationship with hyperfiltration, subsequent rapid eGFR decline, and albuminuria in...

    Laure El ghormli, Hui Wen, Diane Uschner, Morey W. Haymond in Pediatric Nephrology (2023)

  3. No Access

    Article

    Kidney Considerations in Pediatric Obesity

    Chronic kidney disease (CKD) is a common condition and a major cause of morbidity and mortality in adults, but children and adolescents are also at risk for early kidney injury and development of CKD. Obesity ...

    Alexandra Sawyer, Evan Zeitler, Howard Trachtman in Current Obesity Reports (2023)

  4. No Access

    Article

    Estimation of glomerular filtration rate in a pediatric population using non-contrast kidney phase contrast magnetic resonance imaging

    Glomerular filtration rate (GFR) is a key measure of kidney function but often inaccurately ascertained by serum creatinine and cystatin C in pediatrics. In this pilot trial, we evaluated the relationship betw...

    Alex J. Barker, Alexander Berthusen, Tim Vigers, Michal Schafer in Pediatric Nephrology (2023)

  5. No Access

    Article

    Youth-onset type 2 diabetes mellitus: an urgent challenge

    The incidence and prevalence of youth-onset type 2 diabetes mellitus (T2DM) and its complications are increasing worldwide. Youth-onset T2DM has been reported in all racial and ethnic groups, but Indigenous pe...

    Petter Bjornstad, Lily C. Chao, Melanie Cree-Green in Nature Reviews Nephrology (2023)

  6. No Access

    Article

    Plasma levels of carboxylic acids are markers of early kidney dysfunction in young people with type 1 diabetes

    We compared plasma metabolites of amino acid oxidation and the tricarboxylic acid (TCA) cycle in youth with and without type 1 diabetes mellitus (T1DM) and related the metabolites to glomerular filtration rate...

    Timothy Vigers, Carissa Vinovskis, Lu-** Li, Pottumarthi Prasad in Pediatric Nephrology (2023)

  7. No Access

    Article

    Relationship between biomarkers of tubular injury and intrarenal hemodynamic dysfunction in youth with type 1 diabetes

    Early identification of youth with type 1 diabetes (T1D) at risk for diabetic kidney disease may improve clinical outcomes. We examined the cross-sectional relationship between kidney biomarkers neutrophil gel...

    Melissa J. Johnson, Kalie L. Tommerdahl, Carissa Vinovskis in Pediatric Nephrology (2022)

  8. No Access

    Article

    Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates

    The prevalence of youth-onset diabetes is progressing rapidly worldwide, and poor glycemic control, in combination with prolonged diabetes duration and comorbidities including hypertension, has led to the earl...

    Kalie L. Tommerdahl, Allison L. B. Shapiro, Edward J. Nehus in Pediatric Nephrology (2022)

  9. Article

    Open Access

    Nephroprotective effects of GLP-1 receptor agonists: where do we stand?

    Glucagon-like peptide (GLP)-1 receptor agonists are the cornerstone in the treatment of hyperglycemia in many people suffering from type 2 diabetes (T2D). These drugs have potent glucose-lowering actions and, ...

    Charlotte M. Mosterd, Petter Bjornstad, Daniël H. van Raalte in Journal of Nephrology (2020)

  10. No Access

    Article

    Asymptomatic hyperuricaemia: a silent activator of the innate immune system

    Asymptomatic hyperuricaemia affects ~20% of the general population in the USA, with variable rates in other countries. Historically, asymptomatic hyperuricaemia was considered a benign laboratory finding with ...

    Leo A. B. Joosten, Tania O. Crişan, Petter Bjornstad in Nature Reviews Rheumatology (2020)

  11. No Access

    Chapter

    Insulin Resistance and the Kidney in Youth

    Diabetic kidney disease (DKD) remains a leading cause of end-stage renal disease (ESRD) and mortality in the Western world. Early DKD, including albuminuria and hyperfiltration, are common in adolescents with ...

    Petter Bjornstad, David Z. Cherney in Insulin Resistance (2020)

  12. No Access

    Chapter

    Diabetic Nephropathy in Children and Adolescents

    Diabetic nephropathy remains the leading cause of end-stage renal disease (ESRD) and dialysis in the Western world and a major risk factor for cardiovascular disease (CVD) and mortality. Early phenotypes of DN...

    Petter Bjornstad in Diabetic Nephropathy (2019)

  13. No Access

    Article

    Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review

    Insulin resistance (IR) is recognized to play an important role in the pathogenesis of dyslipidemia. This review summarizes the complex interplay between IR and dyslipidemia in people with and without diabetes.

    Petter Bjornstad, Robert H. Eckel in Current Diabetes Reports (2018)

  14. No Access

    Article

    Renal Hyperfiltration in Adolescents with Type 2 Diabetes: Physiology, Sex Differences, and Implications for Diabetic Kidney Disease

    Compared to adult-onset type 2 diabetes (T2D), youth with T2D have a more aggressive phenotype with greater insulin resistance (IR), more rapid β cell decline, and higher prevalence of diabetic kidney disease ...

    Petter Bjornstad, David Z. Cherney in Current Diabetes Reports (2018)

  15. No Access

    Article

    Hyperfiltration and uricosuria in adolescents with type 1 diabetes

    Urine uric acid (UUA) has been implicated in the pathogenesis of diabetic nephropathy via its effect on tubular cells. We hypothesized that the UUA level would be higher in adolescents with type 1 diabetes (T1...

    Petter Bjornstad, Carlos Roncal, Tamara Milagres, Laura Pyle in Pediatric Nephrology (2016)

  16. No Access

    Article

    Measuring glomerular filtration rate by iohexol clearance on filter paper is feasible in adolescents with type 1 diabetes in the ambulatory setting

    Petter Bjornstad, Peter L. Anderson, David M. Maahs in Acta Diabetologica (2016)

  17. No Access

    Article

    Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies

    Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) and dialysis in the Western world. Early DKD, including microalbuminuria and renal hyperfiltration, is common in adolescents...

    Petter Bjornstad, David Z. Cherney, David M. Maahs in Current Diabetes Reports (2016)

  18. Article

    Fructose and uric acid in diabetic nephropathy

    Clinical studies have reported associations between serum uric acid levels and the development of diabetic nephropathy, but the underlying mechanisms remain elusive. There is evidence from animal studies that ...

    Petter Bjornstad, Miguel A. Lanaspa, Takuji Ishimoto, Tomoki Kosugi in Diabetologia (2015)

  19. No Access

    Article

    Update on Estimation of Kidney Function in Diabetic Kidney Disease

    The American Diabetes Association recommends annual assessment of glomerular filtration rate (GFR) to screen for diabetic nephropathy. GFR is measured indirectly using markers that, ideally, are eliminated onl...

    Petter Bjornstad, David Z. Cherney, David M. Maahs in Current Diabetes Reports (2015)

  20. No Access

    Article

    Association of apolipoprotein B, LDL-C and vascular stiffness in adolescents with type 1 diabetes

    LDL cholesterol (LDL-C) is the current lipid standard for cardiovascular disease (CVD)-risk assessment in type 1 diabetes. Apolipoprotein B (apoB) may be helpful to further stratify CVD risk. We explored the a...

    Petter Bjornstad, Nhung Nguyen, Christina Reinick, David M. Maahs in Acta Diabetologica (2015)

previous disabled Page of 2